Literature DB >> 12060446

Risk factors for endometrial hyperplasia: results from a case-control study.

E Ricci1, S Moroni, F Parazzini, M Surace, G Benzi, B Salerio, G Polverino, C La Vecchia.   

Abstract

We analyzed epidemiologic characteristics of women at risk for endometrial hyperplasia (EH), using data from a case-control study. One hundred twenty nine women aged 35-73 (median 51 years) with histologically confirmed complex endometrial hyperplasia without atypies identified at the University of Milan during the period 1990-99 were examined. Controls were 258 non hysterectomized women aged 36-74 (median 52 years), admitted to a network of hospitals covering the same area where cases had been identified for conditions other than gynecological, malignant, or hormone-related. Cases with EH were more educated than controls (OR > 12 years of education vs. < 7: 2.8, 95% CI 1.7-4.8), more frequently obese (OR 2.7, 95% CI 1.5-5.0) and diabetic (OR 2.4, 95% CI 0.8-6.9). Parous women (OR 1.8) and women reporting induced abortions (OR 1.6) showed an increased risk of EH, but the associations were not statistically significant. Compared to premenopausal women, the OR of EH was 0.2 (95% 0.1-0.5) for postmenopausal ones. Compared to women reporting menopause at age 50 or less, the OR of endometrial hyperplasia was 1.5 (95% CI 0.6-3.5) and 2.2 (95%CI 0.7-6.7), respectively, in women with menopause at age 50-52 and > or = 53. Considering postmenopausal women only the OR was 3.1 (95% CI 1.1-9.3) for use of hormonal replacement therapy (HRT). We conclude that this study indicates that high education, obesity, diabetes, and HRT use increase the risk of endometrial hyperplasia.

Entities:  

Mesh:

Year:  2002        PMID: 12060446     DOI: 10.1046/j.1525-1438.2002.01105.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  9 in total

1.  Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

2.  Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy.

Authors:  Meira Epplein; Susan D Reed; Lynda F Voigt; Katherine M Newton; Victoria L Holt; Noel S Weiss
Journal:  Ann Epidemiol       Date:  2009-01       Impact factor: 3.797

3.  Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia.

Authors:  Pinar Kadirogullari; Cemal Resat Atalay; Ozhan Ozdemir; Mustafa Erkan Sari
Journal:  J Clin Diagn Res       Date:  2015-10-01

Review 4.  Therapeutic options for management of endometrial hyperplasia.

Authors:  Vishal Chandra; Jong Joo Kim; Doris Mangiaracina Benbrook; Anila Dwivedi; Rajani Rai
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

Review 5.  New classification system of endometrial hyperplasia WHO 2014 and its clinical implications.

Authors:  Katarzyna Sobczuk; Anna Sobczuk
Journal:  Prz Menopauzalny       Date:  2017-10-12

6.  The significance of post-translational removal of α-DG-N in early stage endometrial cancer development.

Authors:  Sophea Heng; Jemma Evans; Lois A Salamonsen; Tom W Jobling; Guiying Nie
Journal:  Oncotarget       Date:  2017-04-20

7.  Clinical significance of endometrial abnormalities: an observational study on 1020 women undergoing hysteroscopic surgery.

Authors:  Lodovico Patrizi; Carlo Ticconi; Barbara Borelli; Susanna Finocchiaro; Carlo Chiaramonte; Francesco Sesti; Alessandro Mauriello; Caterina Exacoustos; Luisa Casadei
Journal:  BMC Womens Health       Date:  2022-04-07       Impact factor: 2.809

8.  Factors associated with endometrial cancer and hyperplasia among middle-aged and older Hispanics.

Authors:  Ana M Rodriguez; Efstathia Polychronopoulou; Enshuo Hsu; Rahul Shah; Kelly Lamiman; Yong-Fang Kuo
Journal:  Gynecol Oncol       Date:  2020-11-19       Impact factor: 5.482

Review 9.  Hysteroscopy in the management of endometrial hyperplasia and cancer in reproductive aged women: new developments and current perspectives.

Authors:  Salvatore Giovanni Vitale; Gaetano Riemma; Jose Carugno; Benito Chiofalo; George Angelos Vilos; Stefano Cianci; Mehmet Sukru Budak; Bernardo Portugal Lasmar; Antonio Raffone; Ilker Kahramanoglu
Journal:  Transl Cancer Res       Date:  2020-12       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.